Vivani Medical (NASDAQ:VANI – Get Free Report) released its earnings results on Monday. The company reported ($0.11) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.01), Zacks reports.
Vivani Medical Stock Down 2.9 %
Shares of NASDAQ VANI opened at $1.02 on Wednesday. Vivani Medical has a twelve month low of $1.00 and a twelve month high of $2.22. The company has a market cap of $60.42 million, a PE ratio of -2.27 and a beta of 3.20. The business’s 50 day moving average price is $1.13 and its two-hundred day moving average price is $1.21.
Analyst Ratings Changes
Separately, HC Wainwright reaffirmed a “buy” rating and set a $4.00 price target on shares of Vivani Medical in a research report on Wednesday, March 26th.
About Vivani Medical
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Featured Stories
- Five stocks we like better than Vivani Medical
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Will 2025 Be the Year the Energy Sector Finally Breaks Out?
- How to Invest in Biotech Stocks
- NextEra Energy Stock Sees Spike in Bullish Call Activity
- 3 REITs to Buy and Hold for the Long Term
- Top 3 Stocks Mega Investors Are Buying Now
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
